Public information presented according to the provisions of Directive 2001/18/EC
File:
Trial reference:
A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Doc type: